Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-13-058624
Filing Date
2013-11-04
Accepted
2013-11-04 20:04:01
Documents
1
Period of Report
2013-11-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v359298_4.html 4  
1 OWNERSHIP DOCUMENT v359298_4.xml 4 3053
  Complete submission text file 0001144204-13-058624.txt   4470
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
RAYNOR DANIEL (Reporting) CIK: 0001068854 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 131190610